Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Rounds in the General Hospital

PCC
Clozapine: Its Use and Monitoring
Rounds in the General Hospital

July 30, 2024

The authors provide the latest information on clozapine use, including when your patients should receive or avoid taking it, what laboratory tests are required before and during administration, and…
Desta S. Lissanu, Chirag M. Vyas, Carol S. Lim, et al
PCC
Pharmacologic Management of TBI
Rounds in the General Hospital

July 16, 2024

Cognitive complaints, including difficulties with attention, concentration, and memory, are common in patients post-TBI; however, many medications have been studied in the treatment of cognition after TBI. Read on…
Sofia E. Matta, Christina LaCroix, Kaloyan Tanev, et al
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
Rounds in the General Hospital

July 2, 2024

If you have ever been uncertain about how to evaluate patients with a chronic psychotic illness or struggled over how best to manage treatment-resistant schizophrenia, then this case vignette…
Carol S. Lim, Abigail L. Donovan, Chirag M. Vyas, et al
PCC
Neuropsychiatric Complications of Hypervitaminosis D
Rounds in the General Hospital

June 13, 2024

A 28-year-old man presented to the emergency department with severe agitation, insomnia, weakness, constipation, and muscle jerks after nonsuicidal overdosing of vitamin D.
James K. Rustad, Adam Z. Spitz, Brandon C. Wilson, et al
PCC
Impact of Disability on Medical Care
Rounds in the General Hospital

June 6, 2024

Given that many people have disabilities, physicians should develop skills that assess the level of disability, the functional consequence of illness, and the social and physical environments of patients…
Mirza Baig, Andrew S. Chun, Ashika Bains, et al
PCC
Management of Rumination and Obsessions in Primary Care
Rounds in the General Hospital

May 30, 2024

Difficult-to-control negative repetitive thoughts can manifest as ruminations or obsessions. Appropriate early identification and intervention can positively affect the course and prevent an episode of psychiatric illness.
Sharmin Ghaznavi, Charlotte Schiewe, Theodore A. Stern

Page 133

More PCC Articles

JCP
Letter to the Editor

May 25, 2016

For some treatment-resistant patients with OCD, deep brain stimulation (DBS) is a viable option when pharmacotherapy doesn’ t help. The case study of Mr A explains how electroconvulsive therapy…
David L. Rosenthal, Evan Leibu, Amy S. Aloysi, et al
JCP
Original Research

May 25, 2016

Susan G. Ball, Margaret B. Ferguson, James M. Martinez, et al
JCP
Letter to the Editor

May 25, 2016

A number of studies have confirmed the xMHC region on human chromosome 6 to be associated with schizophrenia. Here, Dr Sun discusses her work on identifying schizophrenia candidate genes.
Liya Sun, Ying Qing, Xuhan Yang, et al
JCP
Book Review

May 25, 2016

Robert L. Findling
JCP
Commentary

May 25, 2016

John M. Davis
JCP
Article

May 25, 2016

Read 4 articles on comorbid PTSD on the phenotype of bipolar disorder, PTSD symptoms and the impact of depression on cognition and functioning after stroke.
Erika F. H. Saunders
JCP
Original Research

May 25, 2016

John M. Zajecka, Maurizio Fava, Richard C. Shelton, et al
JCP
Commentary

May 25, 2016

Peter J. Weiden
JCP
Letter to the Editor

May 25, 2016

Ketamine may reduce OCD symptoms in some patients, but IV administration is undesirable. Learn whether oral memantine, another NMDA receptor antagonist, would be a good alternative.
Carolyn I. Rodriguez, Amanda Levinson, Jordana Zwerling, et al
JCP
Meta-Analysis

May 25, 2016

Is one drug good enough? Read this review of 215 double-blind, randomized, placebo-controlled trials to discover which monotherapies have overall short-term efficacy in treating MDD and bipolar depression.
George I. Papakostas, Max A. Martinson, Maurizio Fava, et al
JCP
Article

May 25, 2016

Clozapine is the most effective antipsychotic used in the treatment of refractory schizophrenia. But how do factors like smoking and caffeine intake affect plasma clozapine levels? The authors of…
Jimmy Lee, Robert Bies, Hiroyoshi Takeuchi, et al
JCP
Book Review

May 25, 2016

Jeffrey Stovall

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe